Ahead of the Curve: Inova’s Commitment to Genetic Counseling

Tiffani A. DeMarco, MS, CGC, is a certified genetic counselor and co-manager of the Cancer Genetics Program at the Inova Translational Medicine Institute. She specializes in counseling patients and family members at risk for hereditary cancers. Read Tiffani DeMarco’s profile. Recently, The Washington Post discussed genetic counseling during a live program called “Chasing Cancer.” During…

Read More

Genetic Counselors In Growing Demand as Genetic Testing Takes Off

Benjamin D. Solomon leads the Medical Genomics Division at the Inova Translational Medicine Institute. He performs genome-based research to find the causes of patients’ genetic disorders and is also involved in the clinical care of patients with genetic conditions. He is board certified in clinical genetics and pediatrics. Read Dr. Solomon’s profile. Last year, a…

Read More

Inova Genome News: Looking Ahead

January 2016 Looking Ahead In February 2015, Inova announced the acquisition of the ExxonMobil campus, located across the street from Inova Fairfax Medical Campus. The 117- acre site will be home to the Inova Center for Personalized Health and is the latest example of our commitment to genomic research and personalized medicine. Todd Stottlemyer was…

Read More

The Future of Personalized Health at Inova

John Deeken, MD, is board certified in medical oncology. He specializes in treating patients with head and neck cancer. He is especially interested in using genomics to personalize cancer treatments and in developing targeted therapies. Dr. Deeken serves as associate director for Clinical Research for the Inova Dwight and Martha Schar Cancer Institute. In addition,…

Read More

Pharmacogenomics: Personalized Medicine in Action

Dr. Cannon

Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. His specialty is managing gastrointestinal cancers. Dr. Cannon emphasizes personalized care for his patients and is interested in pharmacogenomics as well as using technology to improve patients’ access to care. Read Dr. Cannon’s profile. Many patients that are receiving chemotherapy ask…

Read More

Inova Translational Medicine Institute (ITMI) and the March of Dimes Prematurity Research Center at Stanford University School of Medicine Announce Partnership

inova logo

      Falls Church, VA, and Palo Alto, CA – March 9, 2015 – The Inova Translational Medicine Institute (ITMI) at Inova Fairfax Medical Campus and the March of Dimes Prematurity Research Center at Stanford University School of Medicine today announced a partnership to discover biomarkers capable of predicting risk of preterm birth using…

Read More

Inova and Personalis Announce Partnership to Advance Genomic Medicine

inova logo

Falls Church, VA and Menlo Park, CA – March 27, 2014 – Inova Translational Medicine Institute and Personalis, Inc. today announced a partnership to advance genomic medicine for Inova’s patient population. Personalis will collaborate with Inova on whole genome analysis and interpretation for undiagnosed syndromes in an effort to provide patients and their families an…

Read More